Database

Startups

Main Industry
Biotechnology
Main Product/Service
1. Cancer Drugs Development:Breast cancer、Liver cancer、Lung cancer、Colorectal cancer、Kidney cancer、Oral cancer、Skin Cancer…cancer drugs development.
2. Precision Medicine:Tumor metastases detection
3. Stem cell application and development:Focus on epigene
Founded Year
2015
Unified Business No.
24722581
Status
Active
Number of Employees
18
Total Paid-in Capital
355,900,000 (NT$)
Location of Company
Taiwan , Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
About the Company
Our company was founded on January 22, 2015, and the initial capital was NT$40 million, Because of the rapid addition of clinical experimental business and R & D investment, the number of initial capital increases up to NT$355.9 million. Moreover, in recent days, the number of the employees grows from 5 people to 20 people,including( 3 Ph.D. and 14 MSc).



more ↓

Similar Companies

Great Novel Therapeutics Biotech & Medicals Corporation

GNTbm focuses on the R&D of oral new drugs in cancer immunotherapy, including tumor microenvironment regulators (TMRs), epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors.

HuniLife Biotechnology, Inc.

HuniLife is committed to developing first-in-class therapeutics for unmet medical need, indicating the innovation-pursuing nature of HuniLife. The products in development at HuniLife are acquired from renowned research institutes or companies through lice
:::
回頁面最頂端